Publication:
Long-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial

Loading...
Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

Panaccione, R.

Colombel, J-F.

Bossuyt, P.

Baert, F.

Vanasek, T.

Danalioglu, A.

Novacek, G.

Armuzzi, A.

Reinisch, W.

Johnson, S.

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source

Keywords

Keywords

Citation

Panaccione R., Colombel J., Bossuyt P., Baert F., Vanasek T., Danalioglu A., Novacek G., Armuzzi A., Reinisch W., Johnson S., et al., -Long-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial-, JOURNAL OF CROHNS & COLITIS, cilt.12, 2018

Endorsement

Review

Supplemented By

Referenced By

1

Views

0

Downloads


Sustainable Development Goals